AKT activator SC79 protects hepatocytes from TNF-α-mediated apoptosis and alleviates <scp>d</scp>-Gal/LPS-induced liver injuryZhen-Tang Jing, Wei Liu, Chaorong Xue et al.|American Journal of Physiology-Gastrointestinal and Liver Physiology|2019Cited by 93
Small hepatitis B virus surface antigen promotes malignant progression of hepatocellular carcinoma via endoplasmic reticulum stress-induced FGF19/JAK2/STAT3 signalingShuxiang Wu, Shuangshuang Ye, Xiaohan Lin et al.|Cancer Letters|2020Cited by 62
PI3K/AKT inhibitors aggravate death receptor-mediated hepatocyte apoptosis and liver injuryWei Liu, Zhen-Tang Jing, Chaorong Xue et al.|Toxicology and Applied Pharmacology|2019Cited by 38
A Novel AKT Activator, SC79, Prevents Acute Hepatic Failure Induced by Fas-Mediated Apoptosis of HepatocytesWei Liu, Xu Lin, Zhen-Tang Jing et al.|American Journal Of Pathology|2018Cited by 37
SIK2 represses AKT/GSK3β/β‐catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatasesXiaoman Dai, Xu Lin|Molecular Oncology|2020Cited by 32